Literature DB >> 10780462

Phosphorothioate G3T4G3 motifs inhibits the early stage of HIV-1 infection.

J Suzuki1, N Miyano-Kurosaki, H Takeuchi, Y Tamura, G Kawai, K Takai, Y Tanaka, R Tanaka, N Yamamoto, H Takaku.   

Abstract

It is well known that G-rich phosphorothioate oligonucleotides (G-rich PS) bind to the V3 loop of HIV-1 gp120 and inhibit HIV-1 infection. In this study, we investigated the inhibitory mechanism of a new type of G-rich PS (PS-G3T4G3) on the replication cycle of HIV-1. PS-G3T4G3 inhibits both cell to cell and cell free infections. Binding and entry assays revealed that the inhibitory step of PS-G3T4G3 occurs at the early stage of HIV-1 infection. V3 loop-specific mAb test showed that PS-G3T4G3 binds to the V3 loop and prevents its interaction with chemokine receptors. These results suggest that PS-G3T4G3 may be a novel candidate for an HIV-1 inhibitor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10780462     DOI: 10.1093/nass/42.1.227

Source DB:  PubMed          Journal:  Nucleic Acids Symp Ser        ISSN: 0261-3166


  2 in total

1.  Newly designed six-membered azasugar nucleotide-containing phosphorothioate oligonucleotides as potent human immunodeficiency virus type 1 inhibitors.

Authors:  Dong-Seong Lee; Kyeong-Eun Jung; Cheol-Hee Yoon; Hong Lim; Yong-Soo Bae
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

2.  Azasugar-containing phosphorothioate oligonucleotide (AZPSON) DBM-2198 inhibits human immunodeficiency virus type 1 (HIV-1) replication by blocking HIV-1 gp120 without affecting the V3 region.

Authors:  Jinjoo Lee; Se Eun Byeon; Ju Yeol Jung; Myeong-Ho Kang; Yu-Jin Park; Kyeong-Eun Jung; Yong-Soo Bae
Journal:  Mol Cells       Date:  2015-01-27       Impact factor: 5.034

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.